FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4240134817> ?p ?o ?g. }

• W4240134817 abstract "In a non-inferiority (NI) trial, analysis based on the intention-to-treat (ITT) principle is anti-conservative, so current guidelines recommend analysing on a per-protocol (PP) population in addition. However, PP analysis relies on the often implausible assumption of no confounders. Randomisation-based efficacy estimators (RBEEs) allow for treatment non-adherence while maintaining a comparison of randomised groups. Fischer et al. have developed an approach for estimating RBEEs in randomised trials with two active treatments, a common feature of NI trials. The aim of this paper was to demonstrate the use of RBEEs in NI trials using this approach, and to appraise the feasibility of these estimators as the primary analysis in NI trials. Two NI trials were used. One comparing two different dosing regimens for the maintenance of remission in people with ulcerative colitis (CODA), and the other comparing an orally administered treatment to an intravenously administered treatment in preventing skeletal-related events in patients with bone metastases from breast cancer (ZICE). Variables that predicted adherence in each of the trial arms, and were also independent of outcome, were sought in each of the studies. Structural mean models (SMMs) were fitted that conditioned on these variables, and the point estimates and confidence intervals compared to that found in the corresponding ITT and PP analyses. In the CODA study, no variables were found that differentially predicted treatment adherence while remaining independent of outcome. The SMM, using standard methodology, moved the point estimate closer to 0 (no difference between arms) compared to the ITT and PP analyses, but the confidence interval was still within the NI margin, indicating that the conclusions drawn would remain the same. In the ZICE study, cognitive functioning as measured by the corresponding domain of the QLQ-C30, and use of chemotherapy at baseline were both differentially associated with adherence while remaining independent of outcome. However, while the SMM again moved the point estimate closer to 0, the confidence interval was wide, overlapping with any NI margin that could be justified. Deriving RBEEs in NI trials with two active treatments can provide a randomisation-respecting estimate of treatment efficacy that accounts for treatment adherence, is straightforward to implement, but requires thorough planning during the design stage of the study to ensure that strong baseline predictors of treatment are captured. Extension of the approach to handle nonlinear outcome variables is also required. The CODA study: ClinicalTrials.gov, identifier: NCT00708656 . Registered on 8 April 2008. The ZICE study trial: ClinicalTrials.gov, identifier: NCT00326820 . Registered on 16 May 2006." @default.
• W4240134817 created "2022-05-12" @default.
• W4240134817 creator A5002227290 @default.
• W4240134817 creator A5011522960 @default.
• W4240134817 creator A5028884075 @default.
• W4240134817 creator A5029702578 @default.
• W4240134817 creator A5031202433 @default.
• W4240134817 creator A5058209400 @default.
• W4240134817 creator A5069947870 @default.
• W4240134817 creator A5070141499 @default.
• W4240134817 creator A5075041271 @default.
• W4240134817 creator A5083810122 @default.
• W4240134817 date "2017-03-09" @default.
• W4240134817 modified "2023-09-25" @default.
• W4240134817 title "The use of randomisation-based efficacy estimators in non-inferiority trials" @default.
• W4240134817 cites W1976152446 @default.
• W4240134817 cites W1976810311 @default.
• W4240134817 cites W1986705681 @default.
• W4240134817 cites W2004345823 @default.
• W4240134817 cites W2008285675 @default.
• W4240134817 cites W2025165014 @default.
• W4240134817 cites W2044763202 @default.
• W4240134817 cites W2054763716 @default.
• W4240134817 cites W2069091142 @default.
• W4240134817 cites W2074501218 @default.
• W4240134817 cites W2099312240 @default.
• W4240134817 cites W2102009624 @default.
• W4240134817 cites W2109763529 @default.
• W4240134817 cites W2120748938 @default.
• W4240134817 cites W2139774670 @default.
• W4240134817 cites W2144512268 @default.
• W4240134817 cites W2146050890 @default.
• W4240134817 cites W2155441883 @default.
• W4240134817 cites W2155760716 @default.
• W4240134817 cites W2156978800 @default.
• W4240134817 cites W2167816518 @default.
• W4240134817 cites W2186657631 @default.
• W4240134817 cites W3124658416 @default.
• W4240134817 cites W4235092737 @default.
• W4240134817 doi "https://doi.org/10.1186/s13063-017-1837-3" @default.
• W4240134817 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28274254" @default.
• W4240134817 hasPublicationYear "2017" @default.
• W4240134817 type Work @default.
• W4240134817 citedByCount "4" @default.
• W4240134817 countsByYear W42401348172019 @default.
• W4240134817 countsByYear W42401348172022 @default.
• W4240134817 crossrefType "journal-article" @default.
• W4240134817 hasAuthorship W4240134817A5002227290 @default.
• W4240134817 hasAuthorship W4240134817A5011522960 @default.
• W4240134817 hasAuthorship W4240134817A5028884075 @default.
• W4240134817 hasAuthorship W4240134817A5029702578 @default.
• W4240134817 hasAuthorship W4240134817A5031202433 @default.
• W4240134817 hasAuthorship W4240134817A5058209400 @default.
• W4240134817 hasAuthorship W4240134817A5069947870 @default.
• W4240134817 hasAuthorship W4240134817A5070141499 @default.
• W4240134817 hasAuthorship W4240134817A5075041271 @default.
• W4240134817 hasAuthorship W4240134817A5083810122 @default.
• W4240134817 hasBestOaLocation W42401348171 @default.
• W4240134817 hasConcept C126322002 @default.
• W4240134817 hasConcept C168563851 @default.
• W4240134817 hasConcept C202953159 @default.
• W4240134817 hasConcept C203092338 @default.
• W4240134817 hasConcept C2908647359 @default.
• W4240134817 hasConcept C44249647 @default.
• W4240134817 hasConcept C535046627 @default.
• W4240134817 hasConcept C71924100 @default.
• W4240134817 hasConcept C77350462 @default.
• W4240134817 hasConcept C99454951 @default.
• W4240134817 hasConceptScore W4240134817C126322002 @default.
• W4240134817 hasConceptScore W4240134817C168563851 @default.
• W4240134817 hasConceptScore W4240134817C202953159 @default.
• W4240134817 hasConceptScore W4240134817C203092338 @default.
• W4240134817 hasConceptScore W4240134817C2908647359 @default.
• W4240134817 hasConceptScore W4240134817C44249647 @default.
• W4240134817 hasConceptScore W4240134817C535046627 @default.
• W4240134817 hasConceptScore W4240134817C71924100 @default.
• W4240134817 hasConceptScore W4240134817C77350462 @default.
• W4240134817 hasConceptScore W4240134817C99454951 @default.
• W4240134817 hasIssue "1" @default.
• W4240134817 hasLocation W42401348171 @default.
• W4240134817 hasLocation W42401348172 @default.
• W4240134817 hasLocation W42401348173 @default.
• W4240134817 hasLocation W42401348174 @default.
• W4240134817 hasOpenAccess W4240134817 @default.
• W4240134817 hasPrimaryLocation W42401348171 @default.
• W4240134817 hasRelatedWork W1974741395 @default.
• W4240134817 hasRelatedWork W2022417792 @default.
• W4240134817 hasRelatedWork W2113848764 @default.
• W4240134817 hasRelatedWork W2584850773 @default.
• W4240134817 hasRelatedWork W2959603226 @default.
• W4240134817 hasRelatedWork W2980596691 @default.
• W4240134817 hasRelatedWork W4225254939 @default.
• W4240134817 hasRelatedWork W4229030331 @default.
• W4240134817 hasRelatedWork W4283740305 @default.
• W4240134817 hasRelatedWork W4366579432 @default.
• W4240134817 hasVolume "18" @default.
• W4240134817 isParatext "false" @default.
• W4240134817 isRetracted "false" @default.
• W4240134817 workType "article" @default.